Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types

Neurochemical Research

Volumn 37, Issue 1, 2012, Pages 134-142

  Lockman, J A ^a,b   Geldenhuys, W J ^c   Bohn, K A ^b   Desilva, S F ^a   Allen, D D ^c   Van Der Schyf, C J ^c  

^a WEST TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Astrocytes; Iron in brain; Metal toxicity; Neurodegenerative diseases; Neurons; Nimodipine; Vascular endothelial cells

Indexed keywords

CALCIUM CHANNEL L TYPE; FERROUS SULFATE; IRON; NIMODIPINE; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN NERVE CELL; CELL PROTECTION; CELL TYPE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; IRON OVERLOAD; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CALCIUM CHANNEL BLOCKERS; IRON; MICROSCOPY, FLUORESCENCE; NIMODIPINE; RATS;

RATTUS;

EID: 84856282075     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0591-2     Document Type: Article

References (59)

1. Hulet SW, Hess EJ, Debinski W, Arosio P, Bruce K, Powers S, Connor Jr. (1999) Characterization and distribution of ferritin binding sites in the adult mouse brain. J Neurochem 72:868-874 (Pubitemid 29055254)
2. Youdim MB, Ben-Shachar D, Yehuda S, Riederer P (1990) The role of iron in the basal ganglion. Adv Neurol 53:155-162
3. Kissel K, Hamm S, Schulz M, Vecchi A, Garlanda C, Engelhardt B (1998) Immunohistochemical localization of the murine transferrin receptor (TfR) on blood-tissue barriers using a novel anti-TfR monoclonal antibody. Histochem Cell Biol 110:63-72 (Pubitemid 28293875)
4. Crichton RR, Ward RJ (2006) Metal-based neurodegeneration: from molecular mechanisms to therapeutic strategies. Wiley, Chichester
5. Connor JR, Menzies SL, Burdo JR, Boyer PJ (2001) Iron and iron management proteins in neurobiology. Pediatr Neurol 25:118-129 (Pubitemid 32830161)
6. Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3:41-51
7. KR Wagner FR Sharp TD Ardizzone A Lu JF Clark 2003 Heme and iron metabolism: role in cerebral hemorrhage J Cereb Blood Flow Metab 23 629 652 10.1097/01.WCB.0000073905.87928.6D 12796711 10.1097/01.WCB.0000073905.87928.6D 1:CAS:528:DC%2BD3sXks1yqsLo%3D Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF (2003) Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 23:629-652. doi: 10.1097/01.WCB.0000073905.87928.6D (Pubitemid 36713668)
8. Finch CA, Hegsted M, Kinney TD, Thomas ED, Rath CE, Haskins D, Finch S, Fluharty RG (1950) Iron metabolism: the pathophysiology of iron storage. Blood 5:983-1008
9. Connor J, Menzies S, St Martin S, Mufson E (1990) Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res 27:595-611
10. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY (1984) Transferrin receptor on endothelium of brain capillaries. Nature 312:162-163 (Pubitemid 14000081)
11. Dickinson TK, Connor Jr. (1998) Immunohistochemical analysis of transferrin receptor: regional and cellular distribution in the hypotransferrinemic (hpx) mouse brain. Brain Res 801:171-181 (Pubitemid 28401661)
12. Aisen P, Wessling-Resnick M, Leibold EA (1999) Iron metabolism. Curr Opin Chem Biol 3:200-206 (Pubitemid 29145787)
13. Moos T, Morgan EH (2004) The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci 1012:14-26 (Pubitemid 38453512)
14. Ke Y, Qian ZM (2007) Brain iron metabolism: neurobiology and neurochemistry. Prog Neurobiol 83:149-173 (Pubitemid 47484044)
15. Moos T, Morgan EH (1998) Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid. J Neurosci Res 54:486-494. doi:10.1002/(SICI)1097-4547(19981115)54:4<486:AID-JNR6>3.0. CO;2-I (Pubitemid 28507027)
16. Qian ZM, Shen X (2001) Brain iron transport and neurodegeneration. Trends Mol Med 7:103-108 (Pubitemid 32201671)
17. Moos T, Rosengren Nielsen T, Skjorringe T, Morgan EH (2007) Iron trafficking inside the brain. J Neurochem 103:1730-1740. doi: JNC497610.1111/j.1471-4159.2007.04976.x (Pubitemid 350126643)
18. Bradbury MW (1997) Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem 69:443-454 (Pubitemid 27327945)
19. Lane DJ, Robinson SR, Czerwinska H, Bishop GM, Lawen A (2010) Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. Biochem J 432:123-132. doi: BJ2010131710.1042/BJ20101317
20. Crichton RR, Wilmet S, Legssyer R, Ward RJ (2002) Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 91:9-18 (Pubitemid 34727756)
21. Thompson KJ, Shoham S, Connor Jr. (2001) Iron and neurodegenerative disorders. Brain Res Bull 55:155-164 (Pubitemid 32722155)
22. Berg D, Gerlach M, Youdim MBH, Double KL, Zecca L, Riederer P, Becker G (2001) Brain iron pathways and their relevance to Parkinson's disease. J Neurochem 79:225-236 (Pubitemid 32988938)
23. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863-873 (Pubitemid 39482155)
24. Salvador GA, Oteiza PI (2011) Iron overload triggers redox-sensitive signals in human IMR-32 neuroblastoma cells. Neurotoxicology 32:75-82. doi: 10.1016/j.neuro.2010.11.006
25. Gaasch JA, Geldenhuys WJ, Lockman PR, Allen DD, Van der Schyf CJ (2007) Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures. Neurochem Res 32:1686-1693. doi: 10.1007/s11064-007- 9313-1 (Pubitemid 47428848)
26. Pelizzoni I, Macco R, Morini MF, Zacchetti D, Grohovaz F, Codazzi F (2011) Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity. Aging Cell 10:172-183. doi: 10.1111/j.1474-9726.2010.00652.x
27. Nunez-Millacura C, Tapia V, Munoz P, Maccioni RB, Nunez MT (2002) An oxidative stress-mediated positive-feedback iron uptake loop in neuronal cells. J Neurochem 82:240-248 (Pubitemid 34774615)
28. Link G, Saada A, Pinson A, Konijn AM, Hershko C (1998) Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells. J Lab Clin Med 131:466-474 (Pubitemid 28259763)
29. Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 233:145-162. doi: 10.1016/j.jns.2005.03.012 (Pubitemid 40812334)
30. Deng X, Vidal R, Englander EW (2010) Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy. Neurosci Lett 479:44-48. doi: 10.1016/j.neulet.2010.05.025
31. Shamoto-Nagai M, Maruyama W, Yi H, Akao Y, Tribl F, Gerlach M, Osawa T, Riederer P, Naoi M (2006) Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome. J Neural Transm 113:633-644. doi: 10.1007/s00702-005-0410-5 (Pubitemid 43673603)
32. Gaasch JA, Lockman PR, Geldenhuys WJ, Allen DD, Van der Schyf CJ (2007) Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res 32:1196-1208. doi: 10.1007/s11064-007-9290-4 (Pubitemid 46817469)
33. Kress GJ, Dineley KE, Reynolds IJ (2002) The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes. J Neurosci 22:5848-5855 (Pubitemid 35387629)
34. Tanaka J, Toku K, Zhang B, Ishihara K, Sakanaka M, Maeda N (1999) Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 28:85-96. (Pubitemid 29530608)
35. Nunez MT, Gallardo V, Munoz P, Tapia V, Esparza A, Salazar J, Speisky H (2004) Progressive iron accumulation induces a biphasic change in the glutathione content of neuroblastoma cells. Free Radic Biol Med 37:953-960. doi: 10.1016/j.freeradbiomed.2004.06.005S0891584904004587 (Pubitemid 39164578)
36. Raps SP, Lai JC, Hertz L, Cooper AJ (1989) Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res 493:398-401. doi: 0006-8993(89)91178-5 (Pubitemid 19183160)
37. Schroeter ML, Mertsch K, Giese H, Muller S, Sporbert A, Hickel B, Blasig IE (1999) Astrocytes enhance radical defence in capillary endothelial cells constituting the blood-brain barrier. FEBS Lett 449:241-244 (Pubitemid 29192914)
38. Aschner M, Vrana KE, Zheng W (1999) Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 20:173-180 (Pubitemid 29268562)
39. Bishop GM, Scheiber IF, Dringen R, Robinson SR (2010) Synergistic accumulation of iron and zinc by cultured astrocytes. J Neural Transm 117:809-817. doi: 10.1007/s00702-010-0420-9
40. Tulpule K, Robinson SR, Bishop GM, Dringen R (2010) Uptake of ferrous iron by cultured rat astrocytes. J Neurosci Res 88:563-571. doi: 10.1002/jnr.22217
41. Hoepken HH, Korten T, Robinson SR, Dringen R (2004) Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J Neurochem 88:1194-1202 (Pubitemid 38280687)
42. Jeong SY, David S (2003) Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 278:27144-27148. doi: 10.1074/jbc.M301988200M301988200 (Pubitemid 36876870)
43. Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C, Yazdanpanah M, Wilson GJ, Schwartz A, Liu PP, Backx PH (2003) L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9:1187-1194. doi: 10.1038/nm920nm920 (Pubitemid 37173704)
44. Zapater P, Moreno J, Horga JF (1997) Neuroprotection by the novel calcium antagonist PCA50938, nimodipine and flunarizine, in gerbil global brain ischemia. Brain Res 772:57-62 (Pubitemid 27501683)
45. Kajikawa H, Ohta T, Yoshikawa Y, Funatsu N, Yamamoto M, Someda K (1979) Cerebral vasospasm and hemoglobins-clinical and experimental studies. Neurol Med Chir 19:61-71 (Pubitemid 9118321)
46. Wan S, Hua Y, Keep RF, Hoff JT, Xi G (2006) Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage. Acta Neurochir Suppl 96:199-202
47. Hua Y, Nakamura T, Keep RF, Wu J, Schallert T, Hoff JT, Xi G (2006) Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg 104:305-312. doi: 10.3171/jns.2006.104.2.305
48. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 45:182-184
49. Berg D, Hochstrasser H, Schweitzer KJ, Riess O (2006) Disturbance of iron metabolism in Parkinson's disease-ultrasonography as a biomarker. Neurotox Res 9:1-13
50. Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC (2003) Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. J Neurochem 86:1142-1148 (Pubitemid 37022190)
51. Jurma OP, Hom DG, Andersen JK (1997) Decreased glutathione results in calcium-mediated cell death in PC12. Free Radic Biol Med 23:1055-1066 (Pubitemid 27451293)
52. Schenck JF, Zimmerman EA (2004) High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 17:433-445. doi: 10.1002/nbm.922 (Pubitemid 39549421)
53. Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56:978-982 (Pubitemid 21922711)
54. Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, Smith MA (2002) Iron: a pathological mediator of Alzheimer disease? Dev Neurosci 24:184-187 (Pubitemid 36151449)
55. Castellani RJ, Smith MA, Nunomura A, Harris PL, Perry G (1999) Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? Free Radic Biol Med 26:1508-1512 (Pubitemid 29302284)
56. Bishop GM, Robinson SR (2001) Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke. Brain Res 907:175-187 (Pubitemid 32595527)
57. Yamamoto A, Shin RW, Hasegawa K, Naiki H, Sato H, Yoshimasu F, Kitamoto T (2002) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J Neurochem 82:1137-1147 (Pubitemid 34966626)
58. Levenson CW (2005) Trace metal regulation of neuronal apoptosis: from genes to behavior. Physiol Behav 86:399-406. doi: 10.1016/j.physbeh.2005.08.010 (Pubitemid 41476412)
59. Yagami T, Ueda K, Sakaeda T, Itoh N, Sakaguchi G, Okamura N, Hori Y, Fujimoto M (2004) Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death. Biochem Pharmacol 67:1153-1165 (Pubitemid 38296794)